Search

Your search keyword '"dermatophytes"' showing total 833 results

Search Constraints

Start Over You searched for: Descriptor "dermatophytes" Remove constraint Descriptor: "dermatophytes" Topic onychomycosis Remove constraint Topic: onychomycosis
833 results on '"dermatophytes"'

Search Results

1. Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents.

3. Clinical evaluation of a dermatophyte RT-PCR assay and its impact on the turn-around-time: A prospective study.

4. Onychomycosis in Patients with Diabetes Mellitus in Africa: A Global Scoping Review, 2000-2021.

5. Dermatophytosis caused by Nannizzia nana (Microsporum nanum): a comprehensive review on a novel pathogen.

6. Superficial fungal infections in the south of France-is fusariosis the next emergent onychopathy?

7. [Clinical picture, causative agents and diagnostics of dermatomycoses].

8. Green natural nail polish modified with essential oils to treat onychomycosis.

9. Fungal Nail Infections amongst Cassava Farmers and Processors in Southwest Nigeria.

10. Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale.

11. Epidemiology of Onychomycosis in Chinese Mainland: A 30-year Retrospective Study.

12. Dermatophytic onychia: Effectiveness of rapid immunochromatographic diagnostic testing directly on samples compared to culture.

13. Use of real time multiplex PCR for the diagnosis of dermatophytes onychomycosis in patients with empirical antifungal treatments.

14. Real-life applicability of the Euroarray dermatomycosis kit in the diagnosis of onychomycosis.

15. Correlation of clinical characteristics, by calculation of SCIO index, with the laboratory diagnosis of onychomycosis.

16. Photodynamic therapy-mediated extirpation of cutaneous-resistant dermatophytosis with Ag@ZnO nanoparticles: an efficient therapeutic approach for onychomycosis.

17. Drug Sensitivity Profile of Fungi Isolated from Onychomycosis Patients and Evaluation of Squalene Epoxidase Mutation in One Terbinafine-Resistant Trichophyton mentagrophytes Species.

18. Onychomycosis: experience of the laboratory of parasitology-mycology of CHU-Joseph Ravoahangy Andrianavalona, Antananarivo, Madagascar.

19. The role of oxidative stress in onychomycosis: Thiol/disulphide homeostasis.

20. Commercial real time PCR implementation for rapid diagnosis of onychomycosis: A new workflow in a clinical laboratory.

21. A Mycological and Molecular Epidemiologic Study on Onychomycosis and Determination In Vitro Susceptibilities of Isolated Fungal Strains to Conventional and New Antifungals.

22. Severe onychomycosis management with oral terbinafine in a kidney transplantation setting: Clinical follow-up by image analysis.

23. Ex vivo potential of a quinoline-derivative nail lacquer as a new alternative for dermatophytic onychomycosis treatment.

24. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.

25. Comparative study between the effect of topical tazarotene 0.1 gel alone vs its combination with tioconazole nail paint in treatment of onychomycosis.

26. Proximal subungual onychomycosis of digitus minimus due to Aspergillus brasiliensis .

27. Study and Development of an Anthroposophical Formula Based on Phosphorus and Formica rufa for Onychomycosis´s Treatment.

28. Onychomycosis: An Updated Review.

29. Specific detection of Trichophyton rubrum and Trichophyton interdigitale based on loop-mediated isothermal amplification (LAMP) from onychomycosis specimens.

30. A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeast.

31. Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate.

32. Clinical evaluation of the DermaGenius® Nail real-time PCR assay for the detection of dermatophytes and Candida albicans in nails.

33. THE PREVALENCE OF ONYCHOMYCOSIS IN THE ZAGREB AREA - THE ROLE OF SABOURAUD AGAR WITHOUT CYCLOHEXIMIDE IN DIAGNOSIS AND THERAPY.

34. Onychomycosis: Which fungal species are involved? Experience of the Laboratory of Parasitology-Mycology of the Rabta Hospital of Tunis.

35. Onychomycosis and Chronic Fungal Disease: Exploiting a Commensal Disguise to Stage a Covert Invasion.

36. Clinico-aetiologic profile of Onychomycoses in a tertiary care centre in northeast India.

37. In vitro biofilms and antifungal susceptibility of dermatophyte and non-dermatophyte moulds involved in foot mycosis.

38. Human Infections with Microsporum gypseum Complex (Nannizzia gypsea) in Slovenia.

39. Tinea Unguium: Diagnosis and Treatment in Practice.

40. Frequency, type and treatment of fungal pathogens in toenail onychomycosis in the central Alpine region of South Tyrol, northern Italy - a 10-year retrospective study from 2004 to 2013.

41. Epidemiology of onychomycosis in Crete, Greece: a 12-year study.

42. Clinical study of Dermatophyte Test Strip, an immunochromatographic method, to detect tinea unguium dermatophytes.

43. Improving Cure Rates in Onychomycosis.

44. Fractional carbon-dioxide (CO2) laser-assisted topical therapy for the treatment of onychomycosis.

45. In vitro and ex vivo infection models help assess the molecular aspects of the interaction of Trichophyton rubrum with the host milieu.

46. Possible Role of Trichophytin Antigen in Inducing Impaired Immunological Clearance of Fungus in Onychomycosis.

47. Concepts in Onychomycosis Treatment and Recurrence Prevention: An Update.

48. Onychomycosis Associated with Exophiala oligosperma in Taiwan.

49. Dermatophytes and other associated fungi in patients attending to some hospitals in Egypt.

50. Descriptive study of onychomycosis in a hospital in São Paulo.

Catalog

Books, media, physical & digital resources